EINDHOVEN, the Netherlands, July 17, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the...
ONWARD® Medical Publishes Annual Sustainability Summary Company strengthens sustainability practices prior to commercializationEINDHOVEN, the...
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy Framework to determine stimulation parameters...
Framework to determine stimulation parameters for ONWARD ARC-EX Therapy are published in the journal...
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET...
EINDHOVEN, the Netherlands, June 26, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the...
ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference CEO Dave Marver and trial participant Gert-Jan Oskam will...
ONWARD® Medical Announces Results of Annual General Meeting of Shareholders THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING...
ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écoulée La revue Nature Medicine a publié...
ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights Nature Medicine published Up-LIFT pivotal trial results Submitted FDA De...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.